Your browser doesn't support javascript.
loading
Second primary cutaneous melanoma in patients with advanced melanoma treated with anti-programmed-death-receptor-1 monoclonal antibodies.
Charvet, E; Kramkimel, N; Chaplain, L; Gantzer, A; Kassem, O; Longvert, C; Blom, A; Dupin, N; Aractingi, S; Hamon, M; Zimmermann, U; Emile, J-F; Sohier, P; Sidibé, T; Saiag, P; Funck-Brentano, E.
Affiliation
  • Charvet E; Departments of, Department of, General and Oncologic Dermatology, Ambroise-Paré Hospital, AP-HP, Boulogne-Billancourt, France.
  • Kramkimel N; Departments of, Department of, Dermatology, Cochin Hospital, AP-HP, Paris, France.
  • Chaplain L; Departments of, Department of, General and Oncologic Dermatology, Ambroise-Paré Hospital, AP-HP, Boulogne-Billancourt, France.
  • Gantzer A; EA 4340 'Biomarkers and Clinical Trials in Cancerology and Hemato-oncology', UVSQ, Université Paris-Saclay, Boulogne-Billancourt, France.
  • Kassem O; Departments of, Department of, General and Oncologic Dermatology, Ambroise-Paré Hospital, AP-HP, Boulogne-Billancourt, France.
  • Longvert C; Departments of, Department of, General and Oncologic Dermatology, Ambroise-Paré Hospital, AP-HP, Boulogne-Billancourt, France.
  • Blom A; Departments of, Department of, General and Oncologic Dermatology, Ambroise-Paré Hospital, AP-HP, Boulogne-Billancourt, France.
  • Dupin N; EA 4340 'Biomarkers and Clinical Trials in Cancerology and Hemato-oncology', UVSQ, Université Paris-Saclay, Boulogne-Billancourt, France.
  • Aractingi S; Departments of, Department of, General and Oncologic Dermatology, Ambroise-Paré Hospital, AP-HP, Boulogne-Billancourt, France.
  • Hamon M; EA 4340 'Biomarkers and Clinical Trials in Cancerology and Hemato-oncology', UVSQ, Université Paris-Saclay, Boulogne-Billancourt, France.
  • Zimmermann U; Departments of, Department of, Dermatology, Cochin Hospital, AP-HP, Paris, France.
  • Emile JF; Departments of, Department of, Dermatology, Cochin Hospital, AP-HP, Paris, France.
  • Sohier P; Department of, Pathology, Ambroise-Paré Hospital, AP-HP, Boulogne-Billancourt, France.
  • Sidibé T; Department of, Pathology, Ambroise-Paré Hospital, AP-HP, Boulogne-Billancourt, France.
  • Saiag P; EA 4340 'Biomarkers and Clinical Trials in Cancerology and Hemato-oncology', UVSQ, Université Paris-Saclay, Boulogne-Billancourt, France.
  • Funck-Brentano E; Department of, Pathology, Ambroise-Paré Hospital, AP-HP, Boulogne-Billancourt, France.
Br J Dermatol ; 184(4): 746-748, 2021 04.
Article in En | MEDLINE | ID: mdl-33098566

Full text: 1 Database: MEDLINE Main subject: Skin Neoplasms / Antineoplastic Agents, Immunological / Melanoma Limits: Humans Language: En Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Main subject: Skin Neoplasms / Antineoplastic Agents, Immunological / Melanoma Limits: Humans Language: En Year: 2021 Type: Article